Jan Aushadi volume powering formulations biz

New Delhi: The drug formulations market in India is expected to grow at a CAGR of 9-10 per cent over the next decade with Jan Aushadhi outlets anticipated to emerge as a much stronger player in the country, according to Glenmark Pharmaceuticals. The domestic formulations market is estimated to be at Rs2 lakh crore, with a growth rate of 11 per cent over the past two decades. “It is projected that the domestic formulations market will maintain a compound annual growth rate (CAGR) of 9-10 per cent over the next decade,” the Mumbai-based drug maker said in its Annual Report for 2023-24.